About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,773 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,773 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7141-7160 of 16,773 trials

UnknownPyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain MetastasisThe purpose of this study is to assess the efficacy and safety of pyrotinib combined with trastuzumab and abraxane in HER2-positive MBC with brain metastasis.NCT04639271·Jinan, Shandong UnknownRadioembolisation and Chemotherapy in Liver Metastatic Breast Cancer PatientsThe goal of this multicentre clinical pilot study is to investigate the feasibility of the addition of Ho-166 radioembolization to chemotherapy in patients with liver metastastic…NCT06142344·Leuven, Vlaams-Brabant and 1 other CompletedSafety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving SurgerySAFE-FORWARD is an observational prospective cohort study.NCT04842409·Florence

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

Not yet recruitingValidity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer PatientsThis study aims to validate a prediction model of brain metastasis risk for females with HR+ breast cancer by using variables collected at diagnosis.NCT06729099

CompletedPhase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.The study comprises two phases: Phase 1a and Phase 1b. The purpose of the study is to observe the safety， tolerability and efficacy of FS-1502.NCT03944499·Bengbu, Anhui and 11 others

CompletedRadiotherapy - Anastrazole Concomitant : Evaluation of the Side EffectsThis study is a description of the radiation effects on the healthy tissues in patients receiving Anastrozole, sequential or in association with radiotherapy.NCT01183832·Amiens and 28 others

WithdrawnPhase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid TumorsThis is a phase II trial of (RQ-07) in advanced solid tumors in prostate, breast or non-small cell lung cancer.NCT02538432

Not yet recruitingAlbumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABCThis is a prospective, single-arm, single-center, open, exploratory clinical study.. Screening for histopathologically confirmed recurrent or metastatic ER-Low positive (1%-10%)…NCT06711094

UnknownEfficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior PyrotinibTo evaluate the efficacy and safety of T-DXd in the treatment of HER2-positive breast cancer with brain metastases after treatment with pyrotinibNCT06135194·Beijing, Beijing Municipality and 1 other

CompletedZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy MarkersThis study is being done to determine if a clinically available MRI sequence called ZTE imaging better visualizes breast biopsy markers made of bone cement compared to the…NCT06873802·Rochester, Minnesota

TerminatedImmediate Implant Breast ReconstructionThe purpose of this study is to study the impact of the immediate implant breast reconstruction for patients with mastectomy and postoperative chest wall radiotherapyNCT02055937·Montpellier

TerminatedGenetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung CancerThis phase I/II trial investigates the side effects of genetically engineered cells called FH-MagIC TCR-T cells and how well they work with atezolizumab in treating patients with…NCT04639245·Seattle, Washington

CompletedMalmö Breast Tomosynthesis Screening TrialTo compare digital breast tomosynthesis (DBT) with full field digital mammography (FFDM) regarding effectiveness as screening modalities.NCT01091545·Malmö

TerminatedA Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BCA Long-term Follow-up Study for Cardiac Safety in the Patients with HER2 Positive Early or Locally Advanced Breast Cancer Who Have Completed the SB3-G31-BCNCT02771795·Vratsa and 39 others

RecruitingA Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BCThis is a Study to Evaluate the Efficacy and Safety of Multiple Combination Therapies with FWD1802 in Subjects with ER-positive/HER2-negative Unresectable Locally Advanced or…NCT07002177·Shanghai

UnknownSienna and Sentimag in Sentinel Lymph Node BiopsyThe aim of this study is to evaluate a new method for the localization of breast cancer sentinel lymph node using Sienna+® and Sentimag® detection in comparison to our standard…NCT03036475

UnknownWhole Breast Irradiation With Intensity Modulated Radiotherapy and Simultaneously Integrated Boost for Early Stage Breast Cancer PatientsThis is a phase II study.NCT01394575·Shanghai, Shanghai Municipality

CompletedCognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT StudyStudies show that cancer survivors have unmet needs, the most frequently cited being fear of recurrence (FCR).NCT03270995·Ottawa, Ontario and 2 others

RecruitingRole of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC StudyIn this multicenter retrospective cohort study the aim is to determine the safety of omission of axillary lymph node dissection in patients with TNBC and HER2+ tumors with…NCT07546695·Basel

CompletedThe BEACON Study (Breast Cancer Outcomes With NKTR-102)The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously…NCT01492101·Flagstaff, Arizona and 152 others

PreviousPage 358 of 839Next